Key result
Above-knee amputation was associated with a significantly higher risk of 30-day perioperative mortality compared to below-knee amputation (OR 4.35; 95% CI 2.56-7.14; P<0.001).
Why the study?
Does above-knee amputation compared to below-knee amputation affect perioperative and long-term mortality in patients with and without diabetes?
Cohort (n=954)
Does above-knee amputation compared to below-knee amputation affect perioperative and long-term mortality in patients with and without diabetes?
Odds Ratio: 4.35 (95% CI 2.56–7.14)
p-value: p=<0.001
Above-knee amputations carry a higher perioperative cardiac risk and worse long-term survival compared to below-knee amputations, independent of diabetes status.
May guide perioperative risk counseling; extends evidence to diabetic and nondiabetic cohorts but remains hypothesis-generating.
In Brief We performed a retrospective review of a vascular surgery quality assurance database to evaluate the perioperative and long-term morbidity and mortality of above-knee amputations (AKA, n = 234) and below-knee amputations (BKA, n = 720) and to examine the effect of diabetes mellitus (DM) (181 of AKA and 606 of BKA patients). All patients in the database who had AKA or BKA from 1990 to May 2001 were included in the study. Perioperative 30-day cardiac morbidity and mortality and 3-yr and 10-yr mortality after AKA or BKA were assessed. The effect of DM on 30-day cardiac outcome was assessed by multivariate logistic regression and the effect on long-term survival was assessed by Cox regression analysis. The perioperative cardiac event rate (cardiac death or nonfatal myocardial infarction) was at least 6.8% after AKA and at most 3.6% after BKA. Median survival was significantly less after AKA (20 mo) than BKA (52 mo) (P < 0.001). DM was not a significant predictor of perioperative 30-day mortality (odds ratio, 0.76 [0.39–1.49]; P = 0.43) or 3-yr survival (Hazard ratio, 1.03 [0.86–1.24]; P = 0.72) but predicted 10-yr mortality (Hazard ratio, 1.34 [1.04–1.73]; P = 0.026). Significant predictors of the 30-day perioperative mortality were the site of amputation (odds ratio, 4.35 [2.56–7.14]; P < 0.001) and history of renal insufficiency (odds ratio, 2.15 [1.13–4.08]; P = 0.019). AKA should be triaged as a high-risk surgery while BKA is an intermediate-risk surgery. Long-term survival after AKA or BKA is poor, regardless of the presence of DM. IMPLICATIONS: Above-knee amputations are a high-risk surgery, whereas below-knee amputations are an intermediate-risk surgery, as defined by the American College of Cardiology/American Heart Association guidelines. Their perioperative mortality is independent of diabetes mellitus but is predicted by renal insufficiency and the site of amputation.
No takes yet. Share an insight, caveat, or question.
Subramaniam et al. (2005) conducted a cohort in Patients undergoing above-knee or below-knee amputations (n=954). Above-knee amputation vs. Below-knee amputation was evaluated on 30-day perioperative mortality (OR 4.35, 95% CI 2.56-7.14, p=<0.001). Above-knee amputation was associated with a significantly higher risk of 30-day perioperative mortality compared to below-knee amputation (OR 4.35; 95% CI 2.56-7.14; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: